Calumet Specialty Products Partners
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Calumet Specialty Products Partners beat expectations on revenues and missed expectations on earnings per share.
Compared to the prior-year quarter, revenue increased significantly and GAAP earnings per share improved significantly.
Gross margins contracted, operating margins increased, and net margins expanded.
Calumet Specialty Products Partners tallied revenue of $1.02 billion. The two analysts polled by S&P Capital IQ looked for revenue of $932.4 million on the same basis. GAAP reported sales were 71% higher than the prior-year quarter's $596.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Non-GAAP EPS came in at $0.24. The three earnings estimates compiled by S&P Capital IQ forecast $0.62 per share on the same basis. GAAP EPS of $0.50 for Q4 were 92% higher than the prior-year quarter's $0.26 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 7.9%, 140 basis points worse than the prior-year quarter. Operating margin was 4.4%, 140 basis points better than the prior-year quarter. Net margin was 2.6%, 100 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $898.0 million. On the bottom line, the average EPS estimate is $0.53.
Next year's average estimate for revenue is $3.70 billion. The average EPS estimate is $2.26.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 412 members out of 438 rating the stock outperform, and 26 members rating it underperform. Among 154 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 147 give Calumet Specialty Products Partners a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Calumet Specialty Products Partners is hold, with an average price target of $21.
Over the decades, small-cap stocks like Calumet Specialty Products Partners have produced market-beating returns, provided they're value-priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: 2 Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.
- Add Calumet Specialty Products Partners to My Watchlist.